<DOC>
	<DOCNO>NCT01158326</DOCNO>
	<brief_summary>This study aim evaluate efficacy safety oral solution paracetamol , chlorpheniramine maleate phenylephrine hydrochloride reduce symptom flu common cold . There randomize , double-blind , placebo-controlled trial . Will include 216 subject , male female , age great 12 less equal 60 year , irrespective color / race symptom recent onset , 6 hour less 48 hour length , characterize Common Cold / Influenza . After clinical evaluation laboratory research subject randomize receive active drug placebo , 10 ml oral solution every 6 hour 48 hour . The follow-up visit hold 2 ( 24 hour first intervention ) 3 day ( 48 hour first intervention ) . The outcome assess effectiveness far consist score symptom assess safety drug accompany emergence adverse event .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Oral Solution Resfenol Reducing Symptoms Common Cold And Flu</brief_title>
	<detailed_description>Infections upper respiratory tract common population , treatment , case involve use symptomatic drug . Paracetamol use analgesic antipyretic , chlorpheniramine antihistamine vasoconstrictor phenylephrine decongestant function . This study aim evaluate efficacy safety oral solution paracetamol , chlorpheniramine maleate phenylephrine hydrochloride reduce symptom flu common cold . There randomize , double-blind , placebo-controlled trial . Volunteers recruit poster Hospital de Clinicals de Porto Alegre , care public hospital network , undergo screen questionnaire first contact . With statistical power 80 % possibility random error 5 % follow study 194 subject . Whereas loss 10 % include 216 subject , male female , age great 12 less equal 60 year , irrespective color / race symptom recent onset , 6 hour less 48 hour , characterize one follow condition : Common Cold , consist least 3 symptom among 10 follow : sneezing , rhinorrhea , nasal congestion , headache , muscle pain , throat discomfort , pain throat , dysphonia , cough , fever , moderate severe use scale severity symptom 4 point ( 0 = none , 1 = mild , 2 = moderate , 3 = severe ) / Influenza consist fever least 38.1 ° C headache moderate severe myalgia / arthralgia moderate severe use scale severity symptom 4 point ( 0 = none , 1 = mild , 2 = moderate , 3 = severe ) . Will include subject agree Terms Consent . Not include study pregnant woman infant know hypersensitivity component formula , research subject experience chronic active exacerbate . After clinical evaluation laboratory research subject randomize receive active drug placebo , 10 ml oral solution every 6 hour 48 hour . Be provide paracetamol rescue co-intervention . Study subject receive diary containing questionnaire symptom . The follow-up visit hold 2 ( 24 hour first intervention ) 3 day ( 48 hour first intervention ) . The outcome assess effectiveness far consist score symptom , rescue medication use , improvement fever , subjective evaluation palatability tolerance treatment compliance . To evaluate safety drug accompany emergence adverse event</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Men woman older 12 year less equal 60 year , without distinction color / race . Presenting symptoms recent onset , 6 hour less 48 hour , characterize one follow condition : Common cold , consist least 3 symptom among 10 follow : sneezing , rhinorrhea , nasal congestion , headache , muscle pain , discomfort throat , sore throat , dysphonia , cough , fever , moderate severe scale severity symptoms 4 point ( 0 = none , 1 = mild , 2 = moderate , 3 = severe ) , OR Flulike symptom consist fever least 38.1 ° C headache moderate severe myalgia / arthralgia moderate severe use scale severity symptom 4 point ( 0 = none , 1 = mild , 2 = moderate , 3 = severe ) . Adequate contraception , woman childbearing age . Do use drug treatment clinical symptom , except case urgency , immediate notification investigator . Patients chronic disease treat monotherapy , stable last three month , may include medical evaluation . Good ability understanding cooperation . Agreement inform consent consent ( IC ) . Assessment exam , medical criterion : Pregnancy test ( rapid urine ) , woman childbearing age , perform prior inclusion ; 12lead electrocardiogram perform consultation Complete blood count platelet count , serum creatinine , serum urea , serum sodium , serum potassium , total bilirubin fraction , gammaglutamyltransferase , alkaline phosphatase , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , prothrombin time , amylase , blood glucose ( possible eight hour fast ) , TSH , urinalysis I , chorionic gonadotropin ( βHCG ) Pregnant lactate woman Known hypersensitivity component formula drug solution active Use alcohol illicit drug use Use monoamine oxidase ( MAO ) barbiturates Diagnosis allergic rhinitis perennial activity Presenting diagnosis disease active acute exacerbate chronic disease ( compensate ) , include hypertension , ischemic heart disease , narrowangle glaucoma , symptomatic prostatic hyperplasia , chronic renal failure , liver disease , infectious tracheobronchitis presumably bacterial pneumonia , streptococcal pharyngitis , asthma chronic obstructive pulmonary disease disease condition opinion investigator modify result study due drug investigation put patient significant risk Clinical evidence immunosuppression ( AIDS , hematologic malignancy , use immunosuppressive drug others ) Patients receive influenza vaccine week inclusion ; Patients opinion attend physician / investigator may need receive antiviral drug treatment infection influenza virus A B ( eg , amantadine , rimantadine , oseltamivir , zanamivir ) Patients opinion attend physician / investigator need receive antibacterial drug treatment acute respiratory infection Drug use prior inclusion time le two dose range drug ( case association , consider reference halflife longer ) : analgesic , NSAIDs , glucocorticoids immunosuppressant , antihistamine , decongestant topical systemic , well medication opinion investigator modify result study due drug investigation interaction place patient significant risk Having participate another clinical research less year .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>reduce symptom</keyword>
	<keyword>event</keyword>
	<keyword>Common Cold</keyword>
	<keyword>flu syndrome</keyword>
	<keyword>Symptomatic treatment Common Cold Flu syndrome</keyword>
</DOC>